Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 2/20 | 0.58 |
| ▸ | GSTP1 | P09211 | 18/20 | 0.54 |
| ▸ | GSTM2 | P28161 | 18/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26424615 | 0.91 | GSTP1 (0.55) | IDO1GSTP1GSTM2 | |
| SCHEMBL3712753 | 0.80 | GSTP1 (0.65) | GSTP1GSTM2 | |
| SCHEMBL26797778 | 0.79 | GSTP1 (0.70) | IDO1GSTP1GSTM2 | |
| SCHEMBL14959168 | 0.78 | GSTP1 (0.64) | IDO1GSTP1GSTM2 | |
| SCHEMBL26425058 | 0.77 | GSTP1 (0.64) | GSTP1GSTM2 | |
| SCHEMBL296924 | 0.74 | IDO1 (1.00) | IDO1GSTP1GSTM2 | |
| SCHEMBL300204 | 0.73 | GSTP1 (0.82) | GSTP1GSTM2 | |
| SCHEMBL3502370 | 0.72 | GSTP1 (0.74) | GSTP1GSTM2 | |
| SCHEMBL13906505 | 0.71 | GSTP1 (0.76) | IDO1GSTP1GSTM2 | |
| SCHEMBL30599546 | 0.71 | GSTP1 (0.57) | GSTP1GSTM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230128972-A1 | Anat Inhibitors and Methods of Use Thereof | Atomwise Inc. | 2023-04-27 | — | — | US | disclosed |
| US-20230128972-A1 | Anat Inhibitors and Methods of Use Thereof | Atomwise Inc. | 2023-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230128972-A1 | Anat Inhibitors and Methods of Use Thereof | AANAT, CHAT, NAT1 | IDO1 1109/4885GSTP1 624/4885GSTM2 510/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.